?

Tatsis Ourania

EVP, Chief Reg. & Quality Off.
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1789815

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
63,680
Price per Share :
$419.92
Equivalence :
$26,740,505.60

Transaction History

  • F
    Form 4
    63,680 Shares After Transaction
    Value : $27,000,956.80
    $1,907,620.99
    02/16/24
  • Footnotes:
    #1 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.
  • F
    Form 4
    60,307 Shares After Transaction
    Value : $25,363,918.06
    $1,418,616.34
    02/20/24
  • S
    Form 4
    59,827 Shares After Transaction
    Value : $25,174,603.33
    Sold $201,979.20
    02/20/24
  • S
    Form 4
    53,523 Shares After Transaction
    Value : $23,502,484.53
    Sold $1,031,908.50
    05/30/24
  • S
    Form 4
    51,273 Shares After Transaction
    Value : $22,816,485.00
    Sold $1,001,250.00
    05/31/24

Get PRO Today.

PRO unlocks 9 more insider transactions made by Tatsis Ourania

Start Free PRO trial Subscribe to PRO